SynBioBeta Speaker
Uli Stilz
Strategic Advisor
Jefferson Life Sciences
May 2026, SynBioBeta
Speaker
Uli Stilz is a life sciences executive and innovation platform builder operating at the intersection of science, strategy, and global innovation ecosystems. Over more than three decades in biopharma, he has focused on translating scientific ambition into therapeutic impact across discovery, translation, and early development.Most recently, Uli served as Corporate Vice President at Novo Nordisk, where he founded and led the Bio Innovation Hub in Cambridge, Massachusetts. The Hub was established as a venture-style, externally anchored R&D and asset-creation platform, connecting academia, biotech startups, venture capital, and research hospitals to build first-in-class early-stage programs with speed, capital discipline, and strong governance. Under his leadership, the platform generated a multi-asset portfolio that now contributes meaningfully to Novo Nordisk’s early pipeline and pioneered new models of corporate–startup co-creation and partnership.Earlier in his career, Uli held senior scientific and strategic leadership roles at Sanofi and Novo Nordisk, contributing to more than 60 development candidates and approximately 30 INDs across multiple therapeutic areas and modalities, including small molecules, biologics, RNA therapeutics, and antibody-based approaches.Trained as a scientist, Uli received his PhD from the Max Planck Institute of Biochemistry under Nobel laureate Hartmut Michel and Professor Dieter Oesterhelt, and completed postdoctoral research at Caltech with Professor Peter Dervan. He is an Honorary Professor at Goethe University Frankfurt and serves in leadership and governance roles across the life sciences ecosystem.Uli’s current work centers on platform strategy, portfolio decision-making, and alliance models at the point where emerging science transitions into scalable therapeutic development. He is particularly interested in how AI-enabled biology, capital allocation, and collaboration structures must evolve to accelerate durable impact for patients.He is a 2024 Fierce 50 Innovation honoree and an EFMC Honorary Fellow.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
17:12:28:30
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.